Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab. [electronic resource]
- Clinical rheumatology Mar 2013
- S19-20 p. digital
Publication Type: Case Reports; Journal Article
1434-9949
10.1007/s10067-010-1412-8 doi
Adult Antibodies, Monoclonal, Murine-Derived--therapeutic use Cryoglobulinemia--complications Cyclophosphamide--therapeutic use Drug Substitution Drug Therapy, Combination Female Glucocorticoids--therapeutic use Humans Immunologic Factors--therapeutic use Pulse Therapy, Drug Remission Induction Rituximab Treatment Outcome Vasculitis, Leukocytoclastic, Cutaneous--complications